(NYSE: TFX) Teleflex's forecast annual revenue growth rate of -1.32% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.
Teleflex's revenue in 2026 is $2,600,599,000.On average, 16 Wall Street analysts forecast TFX's revenue for 2026 to be $97,117,533,924, with the lowest TFX revenue forecast at $94,024,348,943, and the highest TFX revenue forecast at $101,142,911,639. On average, 16 Wall Street analysts forecast TFX's revenue for 2027 to be $101,312,401,227, with the lowest TFX revenue forecast at $97,244,651,115, and the highest TFX revenue forecast at $106,354,716,470.
In 2028, TFX is forecast to generate $105,973,364,897 in revenue, with the lowest revenue forecast at $101,524,263,212 and the highest revenue forecast at $111,481,776,507.